Discounted Cash Flow (DCF) Analysis Levered
InspireMD, Inc. (NSPR)
$1.72
-0.06 (-3.37%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 3.60 | 3.72 | 2.49 | 4.50 | 5.17 | 6.02 | 7.02 | 8.18 | 9.53 | 11.10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | ||||||||||
| Operating Cash Flow | -7.61 | -9.81 | -9.08 | -13.21 | -15.54 | -17.29 | -20.14 | -23.47 | -27.34 | -31.86 |
| Operating Cash Flow (%) | ||||||||||
| Capital Expenditure | -0.07 | -0.28 | -0.09 | -0.34 | -0.47 | -0.36 | -0.42 | -0.49 | -0.57 | -0.66 |
| Capital Expenditure (%) | ||||||||||
| Free Cash Flow | -7.67 | -10.09 | -9.17 | -13.55 | -16.01 | -17.65 | -20.56 | -23.96 | -27.91 | -32.52 |
Weighted Average Cost Of Capital
| Share price | $ 1.72 |
|---|---|
| Beta | 0.882 |
| Diluted Shares Outstanding | 7.87 |
| Cost of Debt | |
| Tax Rate | 0.00 |
| After-tax Cost of Debt | 5.00% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 7.855 |
| Total Debt | 1.20 |
| Total Equity | 13.54 |
| Total Capital | 14.73 |
| Debt Weighting | 8.11 |
| Equity Weighting | 91.89 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 3.60 | 3.72 | 2.49 | 4.50 | 5.17 | 6.02 | 7.02 | 8.18 | 9.53 | 11.10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.61 | -9.81 | -9.08 | -13.21 | -15.54 | -17.29 | -20.14 | -23.47 | -27.34 | -31.86 |
| Capital Expenditure | -0.07 | -0.28 | -0.09 | -0.34 | -0.47 | -0.36 | -0.42 | -0.49 | -0.57 | -0.66 |
| Free Cash Flow | -7.67 | -10.09 | -9.17 | -13.55 | -16.01 | -17.65 | -20.56 | -23.96 | -27.91 | -32.52 |
| WACC | ||||||||||
| PV LFCF | -16.40 | -17.75 | -19.22 | -20.81 | -22.52 | |||||
| SUM PV LFCF | -96.70 |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | 7.62 |
| Free cash flow (t + 1) | -33.17 |
| Terminal Value | -590.19 |
| Present Value of Terminal Value | -408.82 |
Intrinsic Value
| Enterprise Value | -505.52 |
|---|---|
| Net Debt | -3.44 |
| Equity Value | -502.08 |
| Shares Outstanding | 7.87 |
| Equity Value Per Share | -63.78 |